Wellster Healthtech Group

The founders identified a gap in the healthcare market where many individuals with everyday health problems avoid seeking medical advice due to various barriers, including the complexity of the healthcare system and the psychological stress associated with their conditions. Dr. Nothelfer has a background in economics and strategic consulting in the healthcare industry, with previous success leading a company to an IPO on Wall Street. Nico Hribernik has extensive experience in brand management for major B2C brands. They met at an event in 2018 and developed the idea for Wellster.

Wellster operates on a direct-to-consumer business model, integrating telemedicine consultations, drug-based therapies, and digital treatments through its various online portals. These platforms are tailored to specific health topics, such as men's health (gospring.de), women's health (mysummer.de), hair loss (myspring.com), medicinal weight loss (golighter.de), and medical self-tests (easy-testen.de). Patients can access medical diagnoses remotely from a doctor, and prescriptions are sent to either a mail-order or local pharmacy. This approach is designed to assist individuals who may be hesitant to see a doctor in person.

Since its launch in May 2019, Wellster's platforms have been used by over two million people. The company has secured significant funding to support its growth, including a Series B round totaling $60 million. Major investors include HV Capital, Dermapharm AG, Mangrove Capital Partners, and Sevenventures. In October 2024, Wellster announced that it had achieved profitability, positioning it to explore further growth in domestic and international markets, as well as strategic mergers.